Health

  • September 17, 2026

    Nationwide Says Hyperbaric Chamber Death Not Covered

    Nationwide Insurance told a Michigan federal judge that it has no obligation to defend or cover the Oxford Hyperbaric Oxygen Therapy Center and its staff after a 5-year-old boy died there during hyperbaric oxygen therapy, and it urged the court to grant summary judgment relieving it of any duty to defend the policyholders or cover financial liability in the underlying lawsuit.

  • September 17, 2026

    Justices Told Fed. Circ. Erred In Veterinary Software Feud

    A healthcare consulting services company wants the U.S. Supreme Court to review the Federal Circuit's refusal to revive its copyright and contract claims in a fight over rights to healthcare software for a U.S. Army veterinary records system.

  • September 17, 2026

    Tribe Says HHS Defied High Court On Contract Funding

    A California tribe has sued the U.S. Department of Health and Human Services and its Indian Health Service in Washington, D.C., federal court, accusing them of unlawfully slashing about $2.37 million in contract support costs to less than $100,000.

  • September 17, 2026

    Ore. Judge Denies HHS' Attempt To Amend Gender Care Order

    An Oregon federal judge on Thursday rejected the Trump administration's bid to narrow an earlier order that voided a policy declaration central to the government's crackdown on gender-affirming care for minors.

  • September 17, 2026

    Judge OKs Omnicare Plan That Will Settle $1B In Fraud Claims

    A Texas bankruptcy judge on Thursday approved CVS unit Omnicare LLC's Chapter 11 plan, which will spin off the unit from the pharmacy megachain and settle $1 billion in federal fraud claims, after the debtor resolved all objections.

  • September 17, 2026

    Inovalon Investors Reach $44M Deal Over $7.3B Take-Private

    Inovalon Holdings Inc. investors have agreed to a $44 million settlement to end their Delaware Chancery Court suit challenging the healthcare data company's $7.3 billion take-private sale to a Nordic Capital-led consortium, resolving claims that stockholders were misled about conflicts involving the deal's financial advisers.

  • September 17, 2026

    EEOC Says Hospital Spurned Applicant Over Heart Condition

    The U.S. Equal Employment Opportunity Commission filed suit Thursday against a Maryland-based healthcare nonprofit and one of its acute care facilities, claiming they violated disability bias law by pulling a job offer due to a candidate's heart condition.  

  • September 17, 2026

    Fla. Couple Says IVF Clinic Used Stranger's Sperm

    A Florida couple sued a fertility clinic Thursday alleging that it created embryos for the couple with an unknown man's sperm, which they learned after a DNA test showed their daughter has no biological connection to her father.

  • September 17, 2026

    Kennedy Taps 8 For Panel Guiding ACA Preventive Care

    Eight new members have been appointed to a key federal health task force that determines which preventive healthcare services insurers must cover, Health Secretary Robert F. Kennedy Jr. announced Thursday. 

  • September 17, 2026

    NIH Grant Terminations Violate First Amendment, Court Told

    The National Institutes of Health is violating the First Amendment by terminating research grants based on policies aimed at suppressing "disfavored" viewpoints on gender identity, climate change and a host of other topics, researchers told a California federal court in a proposed class action suit.

  • September 17, 2026

    Judge Won't Toss Cannabis Co. Rival Suit, Criticizes AI Misuse

    A Florida federal judge on Wednesday denied a medical marijuana company's bid to get a rival's suit dismissed, called the company's motion to dismiss "sloppy lawyering at best and an AI hallucination at worst," and warned the company's in-house counsel against continued chatbot misuse.

  • September 17, 2026

    Hogan Lovells Hires Original Member Of McDermott+

    Hogan Lovells Cadwalader has hired a new principal adviser in its Washington, D.C.-based health practice who was among the original group of lobbyists who helped launch McDermott+, a recently shuttered subsidiary of McDermott Will & Schulte LLP, her new firm announced. 

  • September 17, 2026

    OpenAI Aims For $1.2T Valuation, More Rumors

    Artificial intelligence giant OpenAI is mulling a private funding round that could value the ChatGPT maker at $1.2 trillion; Blackstone is looking to raise $8 billion for its latest Green Infrastructure Credit Fund; and Japanese chipmaker Kioxia Holdings is looking to raise $10 billion by listing American depositary receipts.

  • September 17, 2026

    Calif. Judge Holds Off On Sanctioning ICE Amid GEO Talks

    A California federal judge deferred imposing sanctions on U.S. Immigration and Customs Enforcement on Thursday after the agency said it's working to give monitors access to health records for detained immigrants at a facility where the judge has twice ordered conditions to be improved.

  • September 17, 2026

    Ex-Conn. Budget Official Flees US Before Corruption Sentence

    Former Connecticut budget official Konstantinos Diamantis slipped out of the United States before learning his fate on federal corruption charges by driving to Florida, taking a boat to the Bahamas, and flying to London, apparently using a Greek passport he was not supposed to possess, attorneys revealed in court Thursday.

  • September 16, 2026

    Fecal Testing Startup Founders Reach $250K Deal With SEC

    Two founders of a now-shuttered fecal testing startup have agreed to pay $125,000 each to put to rest the U.S. Securities and Exchange Commission's allegations that they used a fraudulent insurance billing scheme to get $60 million from investors, according to an announcement made Wednesday.

  • September 16, 2026

    Express Scripts Seeks To Exit AIDS Group's Drug Rate Suit

    Express Scripts called on a Washington federal judge to toss a lawsuit accusing it of using its market power to bully the AIDS Healthcare Foundation into accepting lower reimbursement rates for life-saving drugs, contending Tuesday that the case rehashes allegations a Missouri federal court has already rejected twice.

  • September 16, 2026

    Okla. Mothers Contest Abortion Ban In Fatal Fetal Cases

    A pair of mothers urged an Oklahoma state court Wednesday to bar the state from criminalizing abortion care for pregnant individuals who learn their fetus won't survive birth, arguing that doing so violates fundamental rights under Oklahoma's constitution.

  • September 16, 2026

    Parties Clash Over Scope Of GIPA In DNA Test-Taker's Suit

    An Illinois federal judge is weighing whether the state's genetic privacy law protects against disclosing information about people who have taken genetic tests, with a DNA testing company accused of unlawfully sharing such information with Google arguing Wednesday the statute applies only to disclosure of actual test results.

  • September 16, 2026

    1st Circ. Seems Torn Over Health Plan Surcharge For Smokers

    A First Circuit panel appeared divided Wednesday over whether a casino company is required to refund tobacco use fees after smokers on the company's health plan complete a tobacco cessation program.

  • September 16, 2026

    NJ Judge Likens Hospital's NDA Rule To Soviet Policy

    A New Jersey state judge on Wednesday signaled uncertainty about whether a state-owned hospital can lawfully direct employees to keep quiet during internal investigations, at one point suggesting the nondisclosure agreement at issue looked like something written by a Cold War-era Soviet leader.

  • September 16, 2026

    McLaren Patients' Web Tracking Privacy Claims Advance

    A Michigan federal judge has allowed patients to move forward with claims that McLaren Health Care Corp. and the Barbara Ann Karmanos Cancer Institute allegedly intercepted their electronic communications and benefited from sensitive health information collected through tracking technology embedded in their websites.

  • September 16, 2026

    9th Circ. Revives Doctor's Medicare Sanctions Challenge

    A Ninth Circuit panel revived a doctor's constitutional due process challenge to a 10-year bar the Centers for Medicare and Medicaid Services imposed on his Medicare billing privileges, finding a district court wrongly concluded he had to first exhaust his administrative remedies.

  • September 16, 2026

    80 Hospitals End Suit Over Now Vacated HHS Payment Rule

    A group of 80 hospitals has voluntarily ended a lawsuit against the U.S. Department of Health and Human Services over denied Medicare payment appeals after a D.C. federal court vacated a 2023 rule affecting how those payments were calculated.

  • September 16, 2026

    6th Circ. Ruling Puts Cannabis Deals In Question

    The Sixth Circuit's decision reversing a $31.8 million jury judgment against cannabis giant Curaleaf on the grounds that marijuana is federally illegal is bound to have ramifications for industry players who seek redress in federal courts, attorneys told Law360.

Expert Analysis

  • Series

    Speed Jigsaw Puzzling Makes Me A Better Lawyer

    Author Photo

    My passion for speed puzzling — I can complete a 500-piece jigsaw puzzle in under 50 minutes — has sharpened my legal skills in more ways than one, with both disciplines requiring patience, precision and the ability to keep the bigger picture in mind while working through the details, says Tazia Statucki at Proskauer.

  • Documenting Business Purpose After IRS' 10th Circ. Win

    Author Photo

    Following the Tenth Circuit’s recent Liberty Global v. U.S. decision, which held the economic substance doctrine does not require a threshold relevancy determination, taxpayers can prepare for potential audits by maintaining contemporaneous documentation and taking other steps that demonstrate the business purpose of transactions, say attorneys at Crowell & Moring.

  • How Oregon Ruling Affects Federal Gender Care Crackdown

    Author Photo

    In a favorable development for healthcare providers, an Oregon federal court recently vacated certain U.S. Department of Health and Human Services restrictions on gender-affirming care for minors, but the government's broader campaign against this care, including proposed rulemaking and agency investigations, leaves significant uncertainty, say attorneys at Arnold & Porter.

  • Suit's Dismissal Would Not Settle Gold Card Visa's Legality

    Author Photo

    The government’s recent assertion that the plaintiffs in American Association of University Professors v. Department of Homeland Security lack standing to challenge the Trump administration’s pay-to-play immigration program does not address whether an agency can deem a million-dollar gift evidence of eligibility for immigration benefits carefully defined by Congress, says Jun Li at Reid & Wise.

  • 2 AI Snafus Show Why Attys Can't Outsource Judgment

    Author Photo

    The recent incident involving Sullivan & Cromwell where citations in a filed motion were fabricated by artificial intelligence, as well as a punitive ruling from the Sixth Circuit in U.S. v. Farris, demonstrate that the obligation to supervise AI has belonged and always will belong to lawyers, says John Powell at the Kentucky School Boards Association.

  • NY Opioid Antagonist Mandate Leaves Employers Guessing

    Author Photo

    A recently enacted New York law will require employers that are federally mandated to maintain first-aid supplies to now include an opioid antagonist, but being that it is subject to a complicated Occupational Safety and Health Administration analysis, employers face several unanswered compliance questions, say attorneys at Conn Maciel.

  • Calif. Case Raises Questions For Medical Practice Investors

    Author Photo

    The California attorney general's amicus brief in Art Center v. WCE and the California Medical Association's response highlight how the California appeals court's ruling could significantly affect the structure and enforceability of succession arrangements in medical practice ownership, say attorneys at Ropes & Gray.

  • Previewing FDA Preapproval Access In Psychedelics EO

    Author Photo

    The second of two pathways for psychedelic drug access outlined in President Donald Trump's recent executive order constitutes an unprecedented expansion of the Right to Try Act, which could fundamentally alter the psychedelic access landscape while presenting significant regulatory, operational and legal challenges, say attorneys at Husch Blackwell.

  • Previewing FDA National Priority Vouchers In Psychedelics EO

    Author Photo

    President Donald Trump's recent executive order on psychedelic drug access represents a watershed moment in federal drug policy, but its significance lies in two distinct regulatory pathways, the first being the Commissioner's National Priority Vouchers, which offer a significant opportunity to compress U.S. Food and Drug Administration review, say Kimberly Chew at Husch Blackwell and Odette Hauke at Odette Alina.

  • Series

    Playing Magic: The Gathering Makes Me A Better Lawyer

    Author Photo

    The competitive card game Magic: The Gathering offers me a training ground for the strategic thinking skills crucial to litigation, challenging me to adapt to oft-updated rules, analyze text as complicated as any statute and anticipate my opponent’s next moves, says Christopher Smith at Lash Goldberg.

  • Why Product-Based Public Nuisance Claims May Be Waning

    Author Photo

    The Maryland Supreme Court's recent decision in Express Scripts v. Anne Arundel County is the latest in a national trend of rulings rejecting product-based public nuisance claims — but other forms of government litigation against companies that allegedly increase the cost of public services are likely to continue, say attorneys at Simpson Thacher.

  • What's At Stake For Employers In Fight Over Visa Pause

    Author Photo

    For employers that rely on foreign talent, the Trump administration’s suspension of immigrant visa issuance for the nationals of 75 countries is creating practical problems, and a recently filed lawsuit challenging the pause could determine whether consular processing, for some, ceases to be an individualized process, says attorney Lisa Eisenberg.

  • Improving Well-Being In Law, 10 Years After Landmark Study

    Author Photo

    An important 2016 study revealed significant substance abuse and mental health issues among lawyers, and while the findings helped normalize the conversation around these topics, a decade later, structural change is still needed, says Denise Robinson at PLI.

  • How To Gear Up For Trump's Pharma Tariffs

    Author Photo

    President Donald Trump's proclamation establishing tariffs on certain pharmaceutical products holds a few areas of ambiguity that companies should review and prepare for before the tariffs come into effect later this year, say attorneys at Arnold & Porter.

  • AG Watch: Texas Charts A Course On Investigative Authority

    Author Photo

    The Texas Supreme Court's recent decision in Texas v. PFLAG affirmed, and arguably expanded, the Texas attorney general's civil investigative demand authority, providing a road map that other courts evaluating state attorney general CIDs may find instructive, amid a lack of precedent, say attorneys at Kelley Drye.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.